By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Methylphenidate

Methylphenidate

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|624 words

Methylphenidate

What is Methylphenidate?

Methylphenidate is a central nervous system stimulant medication belonging to the class of psychostimulants. It is primarily prescribed to treat attention deficit hyperactivity disorder (ADHD) in children and adults, as well as narcolepsy. This medication helps improve focus, attention, and impulse control by affecting certain neurotransmitters in the brain.

Uses

Methylphenidate has several documented medical uses:

  • Attention Deficit Hyperactivity Disorder (ADHD): The primary indication for methylphenidate, helping reduce hyperactivity, impulsivity, and inattention in both children and adults
  • Narcolepsy: Used to manage excessive daytime sleepiness and sudden sleep attacks associated with this sleep disorder
  • Treatment-resistant depression: Sometimes prescribed as an adjunct therapy in cases where standard antidepressants have been ineffective
  • Post-stroke depression: May be used in specific cases to help with depression and cognitive function following stroke
  • Cancer-related fatigue: Occasionally prescribed to help manage severe fatigue in cancer patients undergoing treatment

How it works

Methylphenidate works by blocking the reuptake of dopamine and norepinephrine in the brain, particularly in areas responsible for attention and executive function. By preventing these neurotransmitters from being removed from synapses, the medication increases their availability, which helps improve focus, attention, and impulse control. This mechanism explains why a stimulant can paradoxically help calm hyperactive behavior in people with ADHD.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Decreased appetite and weight loss
  • Difficulty sleeping or insomnia
  • Headache
  • Stomach upset or nausea
  • Nervousness or anxiety
  • Increased heart rate
  • Dizziness
  • Mood changes or irritability

Serious side effects to watch for:

  • Chest pain or irregular heartbeat
  • Signs of psychosis, including hallucinations or paranoid thoughts
  • Severe mood changes or suicidal thoughts
  • Signs of circulation problems in fingers or toes
  • Seizures

Warnings and precautions

  • Cardiovascular risks: Should not be used in patients with serious heart problems, structural heart defects, or significant cardiovascular disease due to risk of sudden death
  • Mental health conditions: Use with caution in patients with bipolar disorder, depression, or family history of suicide, as it may worsen these conditions
  • Growth suppression: May slow growth in children; regular monitoring of height and weight is recommended during treatment
  • Pregnancy considerations: Classified as pregnancy category C; should only be used during pregnancy if potential benefits outweigh risks
  • Substance abuse potential: Has potential for abuse and dependence; should be used with caution in patients with history of substance abuse

Interactions

Methylphenidate can interact with several medications and substances:

  • MAO inhibitors: Dangerous interaction that can cause severe high blood pressure; must avoid concurrent use or use within 14 days
  • Blood pressure medications: May reduce effectiveness of antihypertensive drugs by increasing blood pressure
  • Anticoagulants (warfarin): May increase bleeding risk by affecting blood clotting
  • Antidepressants (tricyclics, SSRIs): May increase levels of these medications, potentially causing side effects
  • Antiseizure medications: May reduce effectiveness of seizure medications like phenytoin and phenobarbital
  • Alcohol: Should be avoided as it may worsen side effects and reduce medication effectiveness
  • Caffeine: May increase stimulant effects and side effects like jitteriness and rapid heartbeat
  • Decongestants: May increase cardiovascular side effects when combined with stimulant decongestants

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the formulation and individual response. For immediate-release tablets, the usual starting dose is 5-10 mg twice daily, with gradual increases up to a maximum of 60 mg daily in divided doses. Extended-release formulations typically start at 18-20 mg once daily in the morning, with possible increases up to 72 mg daily. Dosage should always be individualized and determined by a healthcare provider based on patient response, tolerability, and specific medical conditions. Children’s dosages are typically lower and based on body weight and age.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Methylphenidate." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/methylphenidate/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Acyclovir

By
Prof. Giorgi Pkhakadze
02/06/2026

Methotrexate

By
Prof. Giorgi Pkhakadze
02/06/2026

Efavirenz

By
Prof. Giorgi Pkhakadze
02/06/2026

Iron supplements

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up